<?xml version='1.0' encoding='utf-8'?>
<document id="19371259"><sentence text="The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction." /><sentence text="Inflammatory conditions result in increased concentration but reduced potency of some cardiovascular drugs" /><sentence text=" This is associated with increased levels of pro-inflammatory mediators" /><sentence text=" Infliximab reduces pro-inflammatory mediators and reverses the diminishing effect of inflammation on response in the rat" /><sentence text=" We suggested that infliximab treatment would also reverse the effects of inflammation on drug metabolism and clearance" /><sentence text=" We examined hepatic cytochrome P450 content and the pharmacokinetics of verapamil in pre-adjuvant arthritic rats treated with infliximab"><entity charOffset="73-82" id="DDI-PubMed.19371259.s6.e0" text="verapamil" /></sentence><sentence text=" Pre-adjuvant arthritis was induced in male Sprague-Dawley rats with a tail base injection of Mycobacterium butyricum" /><sentence text=" Animals were monitored for symptoms of arthritis, serum nitrite and C-reactive protein" /><sentence text=" On day 6, rats were administered with single s" /><sentence text="c" /><sentence text=" doses of infliximab (10 mg/kg)"><entity charOffset="10-20" id="DDI-PubMed.19371259.s11.e0" text="infliximab" /></sentence><sentence text=" On day 14, a single i" /><sentence text="v" /><sentence text=" dose of racemic verapamil (2 mg/kg) was administered, and S- and R-verapamil concentrations were determined by high performance liquid chromatography"><entity charOffset="9-26" id="DDI-PubMed.19371259.s14.e0" text="racemic verapamil" /><entity charOffset="66-77" id="DDI-PubMed.19371259.s14.e1" text="R-verapamil" /><pair ddi="false" e1="DDI-PubMed.19371259.s14.e0" e2="DDI-PubMed.19371259.s14.e0" /><pair ddi="false" e1="DDI-PubMed.19371259.s14.e0" e2="DDI-PubMed.19371259.s14.e1" /></sentence><sentence text=" Hepatic cytochrome P450 content and verapamil protein binding were also measured" /><sentence text=" Serum nitrite levels were significantly elevated in pre-adjuvant arthritis"><entity charOffset="1-14" id="DDI-PubMed.19371259.s16.e0" text="Serum nitrite" /></sentence><sentence text=" Infliximab did not affect mean nitrite concentrations but there was a significant correlation between nitrite and S-verapamil concentrations as well as cytochrome P450, CYP3A, and CYP1A contents"><entity charOffset="32-39" id="DDI-PubMed.19371259.s17.e0" text="nitrite" /><entity charOffset="103-110" id="DDI-PubMed.19371259.s17.e1" text="nitrite" /><entity charOffset="115-126" id="DDI-PubMed.19371259.s17.e2" text="S-verapamil" /><pair ddi="false" e1="DDI-PubMed.19371259.s17.e0" e2="DDI-PubMed.19371259.s17.e0" /><pair ddi="false" e1="DDI-PubMed.19371259.s17.e0" e2="DDI-PubMed.19371259.s17.e1" /><pair ddi="false" e1="DDI-PubMed.19371259.s17.e0" e2="DDI-PubMed.19371259.s17.e2" /><pair ddi="false" e1="DDI-PubMed.19371259.s17.e1" e2="DDI-PubMed.19371259.s17.e1" /><pair ddi="false" e1="DDI-PubMed.19371259.s17.e1" e2="DDI-PubMed.19371259.s17.e2" /></sentence><sentence text=" Infliximab increased cytochrome P450 enzymes content that had been diminished by pre-adjuvant arthritis but had no significant effect on verapamil protein binding" /><sentence text=" Infliximab partially restores hepatic cytochrome P450 enzyme contents" /><sentence text=" The effect of infliximab on the mean verapamil clearance was not significantly affected due, likely, to the lack of effect on plasma protein binding"><entity charOffset="15-25" id="DDI-PubMed.19371259.s20.e0" text="infliximab" /></sentence><sentence text="" /></document>